RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

May 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-05-09

Reporting Person: RODRIGUEZ RAUL R (Director, CEO, President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-09	Employee Stock Option (Right to Buy)	$2.11	A	450000	Acquired	2027-02-02	Common Stock (450000)	Direct

Footnotes

F1: On February 2, 2017 the reporting person was granted an option to purchase 450,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option.